| Company Name: |
Lynnchem |
| Tel: |
86-(0)29-85992781 17792393971 |
| Email: |
info@lynnchem.com |
| Company Name: |
Novachemistry |
| Tel: |
44-20819178-90 02081917890 |
| Email: |
info@novachemistry.com |
| Company Name: |
Energy Chemical |
| Tel: |
400-0056266 |
| Email: |
marketing1@energy-chemical.com |
|
| | Dabrafenib-D9 Basic information |
| Product Name: | Dabrafenib-D9 | | Synonyms: | Dabrafenib-D9;[2H9]-Dabrafenib;N-[3-[5-(2-amino-4-pyrimidinyl)-2-[1,1-di(methyl-d3)ethyl-2,2,2-d3]-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide;D9-Dabrafenib | | CAS: | 1423119-98-5 | | MF: | C23H20F3N5O2S2 | | MW: | 519.56 | | EINECS: | | | Product Categories: | | | Mol File: | 1423119-98-5.mol |  |
| | Dabrafenib-D9 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: soluble,Methanol: soluble | | form | A solid |
| | Dabrafenib-D9 Usage And Synthesis |
| Uses | Dabrafenib-d9 is the isotope labelled analog of Dabrafenib (D101000); an inhibitor of mutated BRAF kinase. Dabrafenib also has clinical activity with a manageable safety profile in clinical trials of phase 1 and 2 in patients with BRAF(V600)-mutated metastatic melanoma. |
| | Dabrafenib-D9 Preparation Products And Raw materials |
|